Glenmark weighs sale of API business to pare debt : vimarsan

The company had explored a stake sale in its active pharmaceutical ingredient (API) business in 2019 but then opted for a listing in 2021 after spinning off the entity as Glenmark Life Sciences

Related Keywords

Nepal , India , , Eris Life Sciences , Glenmark Pharmaceuticals , Glenmark Life Sciences , Kotak Mahindra Capital Co , Kotak Mahindra Capital , Glenmark Life , Elara Capital , Life Sciences , Glenmark , Pharma , Manufacture , Stake Sale , Debt , Buyout Funds , Active Pharmaceutical Ingredient , Api Business , Listing , Market Capitalisation , Ipo , Promoters , Open Offer , Non Core Assets , Cardiac Brand , Brazel , Cardiovascular Segment , Sub Categories , Dermatology , Oncology , Gross Debt , Net Debt , Us Regulatory Requirements , Monroe Facility , Quarterly Profit , Apis , Liquidity , Anti Trust Ruling , Crisil Credit ,